October 29, 2024 Amneal Pharceuticals, Inc.Letter Agreement • October 31st, 2024 • Patel Chirag K. • Pharmaceutical preparations
UBS FINANCIAL SERVICES INC. A C C O U N T C O N T R O L A G R E E M E N TPatel Chirag K. • October 31st, 2024 • Pharmaceutical preparations • New York
This Agreement is between UBS Financial Services Inc. (“UBSFS”), the party or parties signing this Agreement as Client where indicated below (together and individually, “Client”), UBS AG Stamford Branch, as administrative agent (in such capacity, together with its successors and assigns in such capacity, the “Administrative Agent”) and as calculation agent (in such capacity, together with its successors and assigns, the “Calculation Agent” and together with the Administrative Agent, the “Agents”), each of the Lenders (as defined below) listed from time to time on Schedule A hereto, as collateral agent for itself, the Agents and its Agented Lenders (as defined in the Margin Loan Agreement referred to below) (each such Lender listed on Schedule A, in such capacity as collateral agent, referred to individually as a “Secured Party” and, collectively, as the “Secured Parties”).
